XYLB expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.67385999999548E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.622400E-04 |
Normal-vs-Stage2 |
9.819199999761E-07 |
Normal-vs-Stage3 |
6.22870000022147E-07 |
Normal-vs-Stage4 |
3.62620000027292E-07 |
Stage1-vs-Stage2 |
2.361600E-03 |
Stage1-vs-Stage3 |
1.167360E-04 |
Stage1-vs-Stage4 |
1.009590E-04 |
Stage2-vs-Stage3 |
8.892000E-01 |
Stage2-vs-Stage4 |
7.820600E-01 |
Stage3-vs-Stage4 |
6.091800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.99078999999491E-05 |
Normal-vs-AfricanAmerican |
2.77040000051798E-07 |
Normal-vs-Asian |
4.098100E-02 |
Caucasian-vs-AfricanAmerican |
9.776000E-03 |
Caucasian-vs-Asian |
4.655000E-01 |
AfricanAmerican-vs-Asian |
6.321600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.05760000002064E-06 |
Normal-vs-Female |
4.824100E-04 |
Male-vs-Female |
3.371300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.88049999996876E-06 |
Normal-vs-Age(41-60Yrs) |
2.26589999999804E-05 |
Normal-vs-Age(61-80Yrs) |
1.8089399999921E-05 |
Normal-vs-Age(81-100Yrs) |
7.57670000000044E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.502800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.742200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.309800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.681800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.560800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.390800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.884000E-02 |
Normal-vs-Grade 2 |
9.7419000000043E-05 |
Normal-vs-Grade 3 |
1.73457000000043E-05 |
Normal-vs-Grade 4 |
3.83099999501368E-08 |
Grade 1-vs-Grade 2 |
2.381800E-01 |
Grade 1-vs-Grade 3 |
5.757800E-02 |
Grade 1-vs-Grade 4 |
4.3019000000033E-05 |
Grade 2-vs-Grade 3 |
2.020000E-01 |
Grade 2-vs-Grade 4 |
4.06080000003861E-06 |
Grade 3-vs-Grade 4 |
4.170300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.464400E-03 |
Normal-vs-ccB subtype |
5.07659999593457E-08 |
ccA subtype-vs-ccB subtype |
1.97619698383278E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.98329999999891E-05 |
Normal-vs-N1 |
4.31179999482723E-08 |
N0-vs-N1 |
1.595290E-03 |
|
|